William Arcese
- Hematology top 0.02%
- Hematopoietic Stem Cell Transplantation 156
- Acute Myeloid Leukemia Research 101
- Chronic Myeloid Leukemia Treatments 32
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 18
- Mesenchymal stem cell research 18
- Transplantation top 0.5%
- Immunology top 0.5%
- Oncology top 1%
- Polyomavirus and related diseases 27
- Neutropenia and Cancer Infections 22
-
- Acute Lymphoblastic Leukemia research 68
William Arcese
253 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Hematology 8.9k
- Genetics 2.6k
- Transplantation 497
- Immunology 3.0k
- Oncology 2.6k
Countries citing papers authored by William Arcese
This map shows the geographic impact of William Arcese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Arcese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Arcese more than expected).
Fields of papers citing papers by William Arcese
This network shows the impact of papers produced by William Arcese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Arcese. The network helps show where William Arcese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William Arcese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 4 | |
| 3 | 2019 | 24 | |
| 4 | 2019 | 20 | |
| 5 | 2017 | 25 | |
| 6 | 2017 | 31 | |
| 7 | Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT | 2017 | 1 |
| 8 | 2016 | 20 | |
| 9 | Mother donors improve outcomes after HLA haploidentical T cell-depleted hematopoietic transplantation: A Retrospective Study by the Cell Therapy and Immunobiology Working Party of the EBMT | 2016 | 2 |
| 10 | 2014 | 46 | |
| 11 | 2011 | 185 | |
| 12 | 2011 | 5 | |
| 13 | Quality controls of cord blood units according to JACIE standards are highly predictive in unrelated cord blood transplant | 2009 | 1 |
| 14 | 2006 | 3 | |
| 15 | Autologous peripheral stem cell transplantation of patients with high-risk MDS or AML following MDS results in equivalent outcome when compared to autologous bone marrow transplantation | 2003 | 1 |
| 16 | Peripheral stem cells are the preferred source of stem cells for autologous stem cell transplantation (ASCT) of young patients with MDS or AML following MDS: An analysis of the chronic leukaemia working party of the European blood and marrow transplantation group (EBMT) | 2001 | 4 |
| 17 | 1998 | 72 | |
| 18 | Cord blood transplantation for children with acute leukemia | 1998 | 6 |
| 19 | Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group. | 1991 | 2 |
| 20 | 1988 | 152 |
About William Arcese
William Arcese is a scholar working on Hematology, Transplantation and Genetics, having authored 257 papers that have together received 11.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (156 papers), Acute Myeloid Leukemia Research (101 papers), Acute Lymphoblastic Leukemia research (68 papers), Chronic Myeloid Leukemia Treatments (32 papers), Polyomavirus and related diseases (27 papers), Neutropenia and Cancer Infections (22 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Mesenchymal stem cell research (18 papers). The work is most often cited by research in Hematology (8.9k citations), Genetics (2.6k citations) and Transplantation (497 citations). William Arcese has collaborated with scholars based in Italy, France and Spain. Frequent co-authors include Éliane Gluckman, N Jacobsen, Vanderson Rocha, JM Goldman, HJ Kolb, Myriam Labopin, Dietger Niederwieser, A Schattenberg, Per Ljungman and Francesco Frassoni. Their work appears in journals such as Blood, Bone Marrow Transplantation, British Journal of Haematology, Haematologica and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.